![]() |
|
|
S Rattan and C Moummi
Harvard Digestive Diseases Center, Boston, Massachusetts.
These studies were performed in vitro to investigate the nature of the second messenger for lower esophageal sphincter (LES) smooth muscle relaxation in response to electrical field stimulation (EFS) and vasoactive intestinal polypeptide (VIP). It was seen that VIP, permeant derivatives of the cyclic nucleotide 8-bromo cyclic GMP (BrcGMP) and 8- bromo cyclic AMP (8-BrcAMP), the guanylate cyclase stimulant sodium nitroprusside (SNP), the adenylate cyclase stimulant forskolin, M&B 22,948 (cGMP phosphodiesterase inhibitor) and SK&F 94,120 (cAMP phosphodiesterase inhibitor) caused dose-dependent and tetrocotoxin resistant fall in LES tension. Guanylate cyclase inhibitor methylene blue (MB) (3 x 10(-5) M), caused significant antagonism of fall in LES tension by SNP without modifying the inhibitory response of forskolin. The possible adenylate cyclase inhibitor N-ethylmaleimide (NEM) (1 x 10(-4) M), on the other hand, caused significant antagonism of fall in LES tension by forskolin without any effect on that caused by SNP. The inhibitory responses of 8-BrcGMP and 8-BrcAMP were not modified by MB or NEM. NEM (1 x 10(-4) M) and MB (3 x 10(-5) M) caused significant inhibition of the fall in LES tension with EFS. NEM also caused inhibition of fall in LES tension by VIP. Furthermore, SK&F 94,120 and not M&B 22,948 caused significant potentiation of fall in LES tension by EFS. From these results we conclude that: 1) cAMP and cGMP may act as second messengers for LES relaxation with EFS and VIP, and 2) VIP may act primarily via cAMP system and remains a strong possibility for one of the inhibitory neurotransmitters in the LES.
This article has been cited by other articles:
![]() |
S. Rattan and C. A. Patel Selectivity of ROCK inhibitors in the spontaneously tonic smooth muscle Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G687 - G693. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, M. De Godoy, and S. Rattan Role of Adenylate and Guanylate Cyclases in {beta}1-, {beta}2-, and {beta}3-Adrenoceptor-Mediated Relaxation of Internal Anal Sphincter Smooth Muscle J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1111 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rathi, S. Kazerounian, K. Banwait, S. Schulz, S. A. Waldman, and S. Rattan Functional and Molecular Characterization of beta -Adrenoceptors in the Internal Anal Sphincter J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 615 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. K. Sarma, K. Banwait, A. Basak, A. J. DiMarino, and S. Rattan Inhibitory Effect of beta 3-Adrenoceptor Agonist in Lower Esophageal Sphincter Smooth Muscle: In Vitro Studies J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 48 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Fan, S. Chakder, F. Gao, and S. Rattan Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G32 - G42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rattan and S. Chakder Influence of Heme Oxygenase Inhibitors on the Basal Tissue Enzymatic Activity and Smooth Muscle Relaxation of Internal Anal Sphincter J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1009 - 1016. [Abstract] [Full Text] |
||||
![]() |
Y.-P. Fan, S. Chakder, and S. Rattan Mechanism of action of cholera toxin on the opossum internal anal sphincter smooth muscle Am J Physiol Gastrointest Liver Physiol, July 1, 1999; 277(1): G152 - G160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rattan, Y.-P. Fan, and S. Chakder Mechanism of inhibition of VIP-induced LES relaxation by heme oxygenase inhibitor zinc protoporphyrin IX Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G138 - G145. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Fan, S. Chakder, and S. Rattan Inhibitory Effect of Zinc Protoporphyrin IX on Lower Esophageal Sphincter Smooth Muscle Relaxation by Vasoactive Intestinal Polypeptide and Other Receptor Agonists J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 468 - 474. [Abstract] [Full Text] |
||||